Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004

Legislation no.: 
20
First published: 
26.06.2018
First EIF: 
31.12.2020
Legislation Status: 
In force
Product categories: 
Latest notification: 
Notes: 

Previously notified in N1GBR1, N2GBR8 and N3GBR1
Retained EU Law -
Some European Union law was retained in UK law by virtue of the European Union (Withdrawal) Act 2018 and the European Union (Withdrawal Agreement) Act 2020, with minor modifications to ensure operability.
Specific arrangements may apply in Northern Ireland including by virtue of the Protocol on Ireland/Northern Ireland. The full text of the Protocol on Ireland/Northern Ireland can be accessed via: https://www.gov.uk/government/publications/new-withdrawal-agreement-and-.... Further details on the operation of the Protocol on Ireland/Northern Ireland can be found at: https://www.gov.uk/government/publications/the-northern-ireland-protocol.

On drug precursors

The Drug Precursors Licensing regime is an established regime which derives from the requirements of wider international obligations under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988.
This will mean that companies trading in drug precursors will be required to apply to the Home Office Drugs and Firearms Licensing Unit for:
• Domestic Licences and Registrations – when possessing certain categories of drug precursor chemicals.
• Import and Export Licences – when trading in certain categories of chemicals.
• Pre-export notification – when trading in certain categories of chemicals.
The full licensing requirements and processes can be found at the following link:
https://www.gov.uk/guidance/precursor-chemical-licensing